[HTML][HTML] Soft coral Lobophytum crassum extract inhibits migration and induces apoptosis capabilities in human oral squamous cell carcinoma cells
SM Wang, MC Lu, YM Hsu, CC Huang, CY Fang… - Journal of Dental …, 2024 - Elsevier
Background/purpose The extract of the soft coral Lobophytum crassum has shown an anti-
cancer activity in various cancer cells. However, its effect on the oral squamous cell …
cancer activity in various cancer cells. However, its effect on the oral squamous cell …
[HTML][HTML] Prognostic factors on surgically and non-surgically treated oral squamous cell carcinoma: Advances in survival in fifteen years of follow up
TS Dantas, FB Sousa - Journal of Clinical and Experimental …, 2021 - ncbi.nlm.nih.gov
Prognostic factors on surgically and non-surgically treated oral squamous cell carcinoma:
Advances in survival in fifteen years of follow up - PMC Back to Top Skip to main content NIH …
Advances in survival in fifteen years of follow up - PMC Back to Top Skip to main content NIH …
Outcomes of salvage treatment in patients with recurrent oral squamous cell carcinoma
TC Chen, TH Lo, HC Huang, CW Wang, TL Yang… - Head & …, 2021 - Wiley Online Library
Background The survival outcomes of different salvage treatments for patients with recurrent
oral cancer remain unclear. Methods A total of 556 patients with recurrent oral cancer …
oral cancer remain unclear. Methods A total of 556 patients with recurrent oral cancer …
Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and …
S Limaye, M Menon, S Singh… - Journal of …, 2024 - meridian.allenpress.com
METHODS Here, we report a retrospective case series of patients treated between 2017 and
2023 in the Division of Precision and Medical Oncology at Sir HN Reliance Foundation …
2023 in the Division of Precision and Medical Oncology at Sir HN Reliance Foundation …
A comparison of two methods for the detection of circulating tumour cells in patients with oral cavity cancer
Abstract Background Circulating tumour cells (CTCs) detected in patient blood samples are
relevant as diagnostic and prognostic markers offering insights into tumour behaviour and …
relevant as diagnostic and prognostic markers offering insights into tumour behaviour and …
The efficacy of low-dose immunotherapy in head-and-neck cancer
G Abraham, N Menon, VM Patil, AP Joshi… - Cancer Research …, 2019 - journals.lww.com
Immunotherapy has become the standard of care in many difficult to treat cancers over the
last decade. However, accessibility and cost limit its use in low‑and middle‑income countries …
last decade. However, accessibility and cost limit its use in low‑and middle‑income countries …
Metronomic chemotherapy for scheduling oral cancer surgery during the COVID-19 pandemic
Worldwide, hospitals are facing problems in managing cancer patients during the ongoing
COVID-19 pandemic. Given the immense cancer burden of oral cancer in India, scheduling …
COVID-19 pandemic. Given the immense cancer burden of oral cancer in India, scheduling …
[PDF][PDF] The effectiveness and safety of metronomic chemotherapy in patients with head and neck carcinoma: a systematic review and meta-analysis
X Li, J Wang, T Zhang, J Wang, Z Zheng, C Wang… - 2021 - pdfs.semanticscholar.org
Background: Head and neck carcinoma, usually begins in the squamous cells, not only
seriously endangers the quality of life, but brings a heavy nancial burden for families and …
seriously endangers the quality of life, but brings a heavy nancial burden for families and …
Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma
Background: Patients with platinum-refractory disease who experience early treatment
failure of head and neck squamous cell carcinoma (HNSCC) exhibit a dismal prognosis …
failure of head and neck squamous cell carcinoma (HNSCC) exhibit a dismal prognosis …
[PDF][PDF] 安罗替尼的研究现状及其应用于晚期口腔鳞状细胞癌的治疗前景
楚晨, 孙艳, 尚伟, 张晓春, 葛胜优 - 中华口腔医学研究杂志(电子版), 2020 - zdkqyy.com
晚期口腔鳞状细胞癌(OSCC) 患者生存期短, 预后较差. 由于手术效果不佳, 耐药性,
不良反应等原因, 亟需更安全有效的新型化疗药物以提高晚期OSCC 患者生存质量 …
不良反应等原因, 亟需更安全有效的新型化疗药物以提高晚期OSCC 患者生存质量 …